Difference between revisions of "Dermagraft-TC"
Jump to navigation
Jump to search
(Created page with "{{Construction Site}} right|thumb| Dermagraft-TC which is an artifical skin created from harvested foreskins from infant circumcision.<ref name='Adva...") |
WikiModEn2 (talk | contribs) (Wikify.) |
||
(12 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
− | |||
− | |||
[[Image:Dermagraft.png|right|thumb|]] | [[Image:Dermagraft.png|right|thumb|]] | ||
− | Dermagraft-TC | + | '''Dermagraft-TC''' is an artifical [[skin]] created from harvested [[foreskin| foreskins]] from infant [[circumcision]].<ref name='Advanced Biohealing, 2010'>{{REFweb |
− | {{ | + | |quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue. |
− | | url = http://www.dermagraft.com/about/overview/ | + | |url=http://www.dermagraft.com/about/overview/ |
− | | title = Dermagraft-TC: Overview | + | |title=Dermagraft-TC: Overview |
− | | | + | |last= |
− | | publisher = Advanced Biohealing, Inc. | + | |first= |
− | | | + | |publisher=Advanced Biohealing, Inc. |
− | }} | + | |website= |
− | </ref> It is made and sold by Advanced Tissue Sciences (ATS), which is a corporation based in La Jolla, CA. Dermagraft-TC is [[FDA]] approved,<ref name='MediLexicon 2011-03-06'> | + | |date= |
− | {{ | + | |accessdate=2011-03-06 |
− | | url = http://www.medilexicon.com/drugs/dermagraft-tc.php#GeneralInformation | + | }}</ref> It is made and sold by [[Advanced Tissue Sciences]] (ATS), which is a corporation based in La Jolla, CA. Dermagraft-TC is [[FDA]] approved,<ref name='MediLexicon 2011-03-06'>{{REFweb |
− | | title = Dermagraft-TC | + | |quote=...fibroblast-derived temporary [[skin]] substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA. |
− | | | + | |url=http://www.medilexicon.com/drugs/dermagraft-tc.php#GeneralInformation |
− | | publisher = MediLexicon | + | |title=Dermagraft-TC |
− | | | + | |last= |
− | }} | + | |first= |
− | </ref><ref name='Transplant News 2007-03-28'> | + | |publisher=MediLexicon |
− | {{ | + | |website= |
− | | | + | |date= |
− | | | + | |accessdate=2011-03-06 |
− | | url = http://www.highbeam.com/doc/1G1-47248437.html | + | }}</ref><ref name='Transplant News 2007-03-28'>{{REFnews |
− | | | + | |last= |
− | | | + | |first= |
− | | quote = ...the Food and Drug Administration has approved Dermagraft-TC for marketing, making it the first human fibroblast-derived temporary skin substitute to be approved. | + | |url=http://www.highbeam.com/doc/1G1-47248437.html |
− | }} | + | |title=Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA |
− | </ref> and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of skin.<ref> | + | |date=2007-03-28 |
+ | |publisher=Transplant News | ||
+ | |quote=...the Food and Drug Administration has approved Dermagraft-TC for marketing, making it the first human fibroblast-derived temporary [[skin]] substitute to be approved. | ||
+ | |accessdate=2011-03-06 | ||
+ | }}</ref> and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of [[skin]].<ref>{{REFjournal | ||
+ | |last=Daecher | ||
+ | |init=M | ||
+ | |title=Circumcision | ||
+ | |journal=Icon | ||
+ | |date=1998 | ||
+ | |volume=2 | ||
+ | |issue=2 | ||
+ | |pages=70-73 | ||
+ | |url= | ||
+ | |quote= | ||
+ | |pubmedID= | ||
+ | |pubmedCID= | ||
+ | |DOI= | ||
+ | |accessdate= | ||
+ | }}</ref> | ||
− | + | {{REF}} | |
− | |||
− | |||
− | |||
− | [[Category:Foreskin | + | [[Category:Foreskin product]] |
− | [[Category:Financial | + | [[Category:Financial gain]] |
− | |||
− | [[Category: | + | [[Category:From CircLeaks]] |
[[Category:From IntactWiki]] | [[Category:From IntactWiki]] | ||
+ | |||
+ | [[de:{{FULLPAGENAME}}]] |
Latest revision as of 20:27, 29 October 2022
Dermagraft-TC is an artifical skin created from harvested foreskins from infant circumcision.[1] It is made and sold by Advanced Tissue Sciences (ATS), which is a corporation based in La Jolla, CA. Dermagraft-TC is FDA approved,[2][3] and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of skin.[4]
References
- ↑
Dermagraft-TC: Overview
, Advanced Biohealing, Inc.. Retrieved 6 March 2011.
Quote:Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.
- ↑
Dermagraft-TC
, MediLexicon. Retrieved 6 March 2011.
Quote:...fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA.
- ↑ (28 March 2007)."Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA", Transplant News. Retrieved 6 March 2011.
Quote:...the Food and Drug Administration has approved Dermagraft-TC for marketing, making it the first human fibroblast-derived temporary skin substitute to be approved.
- ↑ Daecher M. Circumcision. Icon. 1998; 2(2): 70-73.